Your browser doesn't support javascript.
loading
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis.
Delmas, P D; Calvo, G; Boers, M; Abadie, E; Avouac, B; Kahan, A; Kaufman, J M; Laslop, A; Lekkerkerker, J F; Nilsson, P; Van Zwieten-Boot, B; Kreutz, G; Reginster, J Y.
Affiliation
  • Delmas PD; INSERM Research Unit 403 and Claude Bernard University of Lyon, France. delmas@lyon151.inserm.fr
Osteoporos Int ; 13(1): 1-5, 2002 Jan.
Article in En | MEDLINE | ID: mdl-11878450
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Controlled Clinical Trials as Topic Type of study: Clinical_trials / Guideline Aspects: Ethics Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2002 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Controlled Clinical Trials as Topic Type of study: Clinical_trials / Guideline Aspects: Ethics Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2002 Document type: Article Affiliation country: Francia Country of publication: Reino Unido